Technetium-labelled liposome imaging for deep-seated infection

Area of Science:

• Nuclear medicine
• Radiopharmaceutical development
• Liposome technology

Background:

• Focal inflammatory lesions in deep-seated sepsis and rheumatoid arthritis pose diagnostic challenges.
• Developing effective radioisotopic tracers is crucial for accurate medical imaging.

Observation:

• Negatively charged phospholipid liposomes were successfully labeled with technetium 99m.
• Human volunteers and patients received intravenous injections of the radiolabeled liposomes.
• Scintigraphy was performed the following day to assess tracer distribution and uptake.

Findings:

• Significant uptake of technetium 99m-labeled liposomes was observed in the liver and spleen.
• No radioactivity was associated with the intestines, indicating targeted biodistribution.
• Radioactive uptake was visualized in infected prosthetic joints, tubo-ovarian abscesses, and osteomyelitis.
• In a patient with active rheumatoid arthritis, uptake was confined to clinically affected joints.

Implications:

• Technetium 99m-labeled liposomes demonstrate potential as a diagnostic tracer for focal inflammatory conditions.
• This approach may improve the detection and localization of deep-seated infections and inflammatory joint diseases.
• Further research could validate the clinical utility of these radiolabeled liposomes in various inflammatory pathologies.